A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy

Background and Objectives: Studies have shown a lower prevalence of anti-SARS-CoV-2 antibodies in patients with inflammatory bowel disease (IBD), including amongst those receiving biological therapy. Aims were to determine the seroprevalence of anti-SARS-CoV-2 antibodies in IBD patients and to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Ruscio, Mirko, Lunardi, Gianluigi, Buonfrate, Dora, Gobbi, Federico, Bertoli, Giulia, Piccoli, Donatella, Conti, Antonio, Geccherle, Andrea, Variola, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539305/
https://www.ncbi.nlm.nih.gov/pubmed/34684085
http://dx.doi.org/10.3390/medicina57101048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539305/
https://www.ncbi.nlm.nih.gov/pubmed/34684085
http://dx.doi.org/10.3390/medicina57101048

Ejemplares similares